This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Multiple acyl-CoA dehydrogenase (MAD) deficiency is caused by inherited deficiency of electron transfer flavoprotein (ETF) or ETF:ubiquinone oxidoreductase.1 The disease course is highly variable ranging from the neonatal (lethal) form with congenital abnormalities (type I), hypoglycemic encephalopathy without congenital abnormalities (type II), to myopathy (type III).1 Homozygosity for null mutations is usually associated with type I, whereas little residual activity is found in type II, and a relatively high residual activity in type III.2 Some patients with late-onset MAD deficiency have been reported previously but few have been described in detail.3,4
Case report.
A 56-year-old man presented with progressive proximal myopathy of unknown origin. His family history and development were unremarkable. Before the onset of symptoms his exercise tolerance was unimpaired. His nutrition was predominantly based on animal products and was rich in fat and protein; alcohol abuse was not reported. At age 42 years he started having intermittent weakness and pain predominantly of the proximal limbs which was …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
Child Neurology: Recurrent rhabdomyolysis due to a fatty acid oxidation disorder
Short-chain acyl–CoA dehydrogenase deficiency
Pearls & Oy-sters: A curable myopathy manifesting as exercise intolerance and respiratory failure
Mitochondrial trifunctional protein deficiency associated with recurrent myoglobinuria in adolescence